732 related articles for article (PubMed ID: 30463045)
1. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
[TBL] [Abstract][Full Text] [Related]
2. Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease.
Rahman SO; Kaundal M; Salman M; Shrivastava A; Parvez S; Panda BP; Akhter M; Akhtar M; Najmi AK
Eur J Pharmacol; 2020 Dec; 889():173522. PubMed ID: 32866503
[TBL] [Abstract][Full Text] [Related]
3. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
[TBL] [Abstract][Full Text] [Related]
4. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
Siddiqui N; Ali J; Parvez S; Najmi AK; Akhtar M
Neurochem Res; 2023 Sep; 48(9):2714-2730. PubMed ID: 37079222
[TBL] [Abstract][Full Text] [Related]
6. Effects of Astaxanthin from Shrimp Shell on Oxidative Stress and Behavior in Animal Model of Alzheimer's Disease.
Taksima T; Chonpathompikunlert P; Sroyraya M; Hutamekalin P; Limpawattana M; Klaypradit W
Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31690015
[TBL] [Abstract][Full Text] [Related]
7. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
[TBL] [Abstract][Full Text] [Related]
8. Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption.
Ghasemi R; Zarifkar A; Rastegar K; maghsoudi N; Moosavi M
Neuropharmacology; 2014 Oct; 85():113-20. PubMed ID: 24881967
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1-42) induced neurotoxicity in animal model of Alzheimer's disease.
Som S; Antony J; Dhanabal S; Ponnusankar S
Metab Brain Dis; 2022 Feb; 37(2):359-372. PubMed ID: 35023028
[TBL] [Abstract][Full Text] [Related]
10. Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxicity in an animal model of Alzheimer's disease in rats.
Kalra J; Kumar P; Majeed AB; Prakash A
Pharmacol Biochem Behav; 2016; 146-147():1-12. PubMed ID: 27106205
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and Aβ
Patel R; Kaur K; Singh S
Inflammopharmacology; 2021 Aug; 29(4):1157-1168. PubMed ID: 34235591
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
[TBL] [Abstract][Full Text] [Related]
13. Pinus halepensis essential oil attenuates the toxic Alzheimer's amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus.
Postu PA; Sadiki FZ; El Idrissi M; Cioanca O; Trifan A; Hancianu M; Hritcu L
Biomed Pharmacother; 2019 Apr; 112():108673. PubMed ID: 30784941
[TBL] [Abstract][Full Text] [Related]
14. Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.
Bagheri M; Joghataei MT; Mohseni S; Roghani M
Neurobiol Learn Mem; 2011 Mar; 95(3):270-6. PubMed ID: 21144907
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
16. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
Sachdeva AK; Chopra K
J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
[TBL] [Abstract][Full Text] [Related]
17. Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.
Fahanik-Babaei J; Baluchnejadmojarad T; Nikbakht F; Roghani M
Metab Brain Dis; 2019 Feb; 34(1):191-201. PubMed ID: 30421246
[TBL] [Abstract][Full Text] [Related]
18. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
19. The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses.
Wang P; Jiang S; Cui Y; Yue Z; Su C; Sun J; Sheng S; Tian J
Neuroscience; 2011 Jan; 173():169-78. PubMed ID: 21055450
[TBL] [Abstract][Full Text] [Related]
20. Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer's disease: an exploration of underlying mechanisms.
Kiasalari Z; Heydarifard R; Khalili M; Afshin-Majd S; Baluchnejadmojarad T; Zahedi E; Sanaierad A; Roghani M
Psychopharmacology (Berl); 2017 Jun; 234(12):1841-1852. PubMed ID: 28303372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
